Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Parissis

Showing results (191-200 of 238) with videos related to

Pageof 24
Sort By:
Annals of Neurology|August 23, 2020
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic StrokeSokratis Triantafyllou, Aristeidis H Katsanos, Polychronis Dilaveris, et al.
Journal of Clinical Medicine|October 14, 2023
Rationale and Design of Heart Failure Prevalence and Evolution of Heart Failure in Diabetes Mellitus Type II Patients at High Risk (HF-LanDMark Study)John Parissis, Christos Georgiou, Vasiliki Bistola, et al.
Infectious Diseases and Therapy|May 14, 2020
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study GroupDimitrios Velissaris, George Dimopoulos, John Parissis, et al.
Journal of Clinical Medicine|November 21, 2019
Potential Utility of Neurosonology in Paroxysmal Atrial Fibrillation Detection in Patients with Cryptogenic StrokeChrissoula Liantinioti, Lina Palaiodimou, Konstantinos Tympas, et al.
European Journal of Heart Failure|March 31, 2015
Clinical picture and risk prediction of short-term mortality in cardiogenic shockVeli-Pekka Harjola, Johan Lassus, Alessandro Sionis, et al.
ESC Heart Failure|October 19, 2021
Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literatureRazvan I Radu, Tuvia Ben Gal, Magdy Abdelhamid, et al.
European Journal of Heart Failure|May 17, 2021
Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrumVasiliki Bistola, Panagiotis Simitsis, John Parissis, et al.
Neurology|June 8, 2018
Percutaneous patent foramen ovale closure for secondary stroke prevention: Network meta-analysisGeorgios Tsivgoulis, Aristeidis H Katsanos, Dimitris Mavridis, et al.
Journal of Thrombosis and Thrombolysis|February 14, 2020
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery diseaseIgnatios Ikonomidis, Konstantinos Katogiannis, Elias Kyriakou, et al.
European Heart Journal. Acute Cardiovascular Care|August 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shockMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
Pageof 24

Showing results (191-200 of 238) with videos related to

Sort By:
Pageof 24
Annals of Neurology|August 23, 2020
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic StrokeSokratis Triantafyllou, Aristeidis H Katsanos, Polychronis Dilaveris, et al.
Journal of Clinical Medicine|October 14, 2023
Rationale and Design of Heart Failure Prevalence and Evolution of Heart Failure in Diabetes Mellitus Type II Patients at High Risk (HF-LanDMark Study)John Parissis, Christos Georgiou, Vasiliki Bistola, et al.
Infectious Diseases and Therapy|May 14, 2020
Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study GroupDimitrios Velissaris, George Dimopoulos, John Parissis, et al.
Journal of Clinical Medicine|November 21, 2019
Potential Utility of Neurosonology in Paroxysmal Atrial Fibrillation Detection in Patients with Cryptogenic StrokeChrissoula Liantinioti, Lina Palaiodimou, Konstantinos Tympas, et al.
European Journal of Heart Failure|March 31, 2015
Clinical picture and risk prediction of short-term mortality in cardiogenic shockVeli-Pekka Harjola, Johan Lassus, Alessandro Sionis, et al.
ESC Heart Failure|October 19, 2021
Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literatureRazvan I Radu, Tuvia Ben Gal, Magdy Abdelhamid, et al.
European Journal of Heart Failure|May 17, 2021
Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrumVasiliki Bistola, Panagiotis Simitsis, John Parissis, et al.
Neurology|June 8, 2018
Percutaneous patent foramen ovale closure for secondary stroke prevention: Network meta-analysisGeorgios Tsivgoulis, Aristeidis H Katsanos, Dimitris Mavridis, et al.
Journal of Thrombosis and Thrombolysis|February 14, 2020
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery diseaseIgnatios Ikonomidis, Konstantinos Katogiannis, Elias Kyriakou, et al.
European Heart Journal. Acute Cardiovascular Care|August 11, 2022
Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shockMari Hongisto, Johan Lassus, Tuukka Tarvasmäki, et al.
Pageof 24